bioRxivImmunology
Endocrine autoimmune disease as a fragility of immune-surveillance against hypersecreting mutants
Abstract
Many endocrine organs show prevalent autoimmune diseases (AID) such as type-1-diabetes and Hashimotos-thyroiditis. The fundamental origins of these diseases is unclear. Here we address AID from the viewpoint of feedback control. Endocrine tissues maintain their mass by feedback-loops that balance cell proliferation and removal according to input signals related to the hormone function. Such feedback is unstable to mutant cells that mis-sense the signal, and therefore hyper-proliferate and hyper-secrete the hormone. We hypothesize that in order to prevent these mutants from expanding, each organ has a dedicated autoimmune surveillance of hyper-secreting mutants (ASHM), in which hyper-secreting cells are preferentially eliminated, at the cost of a fragility to AID. ASHM correctly predicts the identity of the self-antigens and the presence of T-cells against these self-antigens in healthy individuals. It offers a predictive theory for which tissues get frequent AID, and which do not and instead show frequent mutant-expansion disease (e.g. hyperparathyroidism).
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Conjecture: Some auto-immune diseases are caused by the tissue, not a problem with the immune system
Harlan Robins·bioRxiv·Nov 20, 2015
- Immune-parenchymal multicellular niches are shared across distinct thyroid autoimmune diseases
Michelle Rengarajan, Rachelly Normand, … Alexandra–Chloé Villani·bioRxiv·Mar 30, 2025
- Plasmacytoid dendritic cells are functionally exhausted while non-haematopoietic sources of type I interferon dominate human autoimmunity
A. Psarras, A. Alase, … E. M. Vital·bioRxiv·Dec 20, 2018
- Targeting BMI-1 to deplete antibody-secreting cells in autoimmunity
J. Polmear, L. Hailes, … K. Good-Jacobson·bioRxiv·Jul 27, 2023
- Polyfunctional IL-21+ IFNg+ T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy
Nicole Huang, Jessica Ortega, … Melissa G. Lechner·JCI InsightPeer-reviewed·Jul 7, 2025
- Overexpression of HLA class I predominantly on alpha cell in at risk individuals for type 1 diabetes
M. A. Benkahla, S. Sabouri, … M. G. von Herrath·bioRxiv·Jul 13, 2020